表观遗传学
DNA甲基化
心肺适能
镉
有氧运动
生物
镉暴露
生理学
内科学
内分泌学
甲基化
生物信息学
身体素质
有氧能力
耐力训练
全血
后生
史诗
遗传学
最大VO2
医学
临床试验
心血管健康
表观遗传疗法
运动生理学
作者
Guilherme da Silva Rodrigues,Natália Yumi Noronha,João Gabriel Ribeiro de Lima,Chanachai Sae‐Lee,Pitaksin Chitta,Andressa Crystine da Silva Sobrinho,Isabella Harumi Yonehara Noma,Luísa Maria Diani,Fernando Barbosa Júnior,Carla Barbosa Nonino,Lígia Moriguchi Watanabe,Carlos Roberto Bueno Júnior
出处
期刊:Epigenomics
[Future Medicine]
日期:2026-05-04
卷期号:18 (5): 575-589
被引量:1
标识
DOI:10.1080/17501911.2026.2672104
摘要
Introduction Cadmium is a toxic heavy metal linked to impaired cardiorespiratory fitness and altered DNA methylation patterns. This study investigated the effects of 14 weeks of combined exercise training on epigenetic modifications and blood cadmium levels in women with varying aerobic fitness.Methods Participants underwent three weekly training sessions totaling 180 minutes. Pre- and post-intervention evaluations included anthropometry, blood pressure, physical performance, and heavy metal analysis. DNA methylation was assessed using the Illumina EPIC BeadChip.Results Based on baseline 6-minute walk test and age, participants were divided into lower (LAF, n = 32) and higher (HAF, n = 17) aerobic fitness groups. Pre-intervention, LAF had significantly higher cadmium levels than HAF (p = 0.003). After the intervention, LAF showed a significant reduction of 0.056 µg/L (63%), while HAF decreased by 0.019 µg/L (28%) (p = 0.046). A total of 513 differentially methylated regions (DMRs) related to cadmium were identified, with enrichment in pathways associated with neurodegeneration-related processes. Intrinsic epigenetic age acceleration (IEAA) also differed significantly between groups at baseline.Conclusion Combined exercise training significantly reduced cadmium levels in women aged 50–70 years with low aerobic fitness and induced locus-specific epigenetic changes associated with cadmium-related pathways, which may be relevant to pathways implicated in age-related neurological conditions.Clinical Trial The study was registered in the Brazilian Clinical Trials Registry (ReBEC; identifier RBR-3g38dx).
科研通智能强力驱动
Strongly Powered by AbleSci AI